Press releases
Year-end report July 1, 2021 – June 30, 2022
30 August, 2022Summary of the fourth quarter (2022-04-01 – 2022-06-30) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss amounted to MSEK -2,1 (-1,5) Earnings per share* SEK -0.11 (-0.10) * Before […]
DexTech Medical’s application for myeloma study approved
10 August, 2022The application for a phase1 study regarding OsteoDex’s effect on patients with multiple myeloma that was submitted to the Medical Products Agency on 2022-06-23 has been approved and granted permission […]
Report from the Extraordinary General Meeting
11 May, 2022Today, May 11, 2022, the Extra General Meeting of DexTech Medical AB was held. Below is a summary of the decisions made. All decisions were made by the required majority. […]
Interim report July 1, 2021 – March 31, 2022
29 April, 2022By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. Summary of the third quarter (2022-01-01 – 2022-03-31) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss […]
Notice of Extraordinary General Meeting in DexTech Medical AB
25 April, 2022Dextech Medical AB’s shareholders are welcome to attend the Extraordinary General Meeting which will take place on Wednesday, May 11, 2022 at 10.00 in IVA’s conference center, Royal. Academy of […]
DexTech Medical strengthens its organization, Andreas Segerros proposed as new Chairman of the Board
6 April, 2022The Board of Directors of DexTech Medical AB (“DexTech” or “the Company”) has decided to strengthen the Company’s organization with the main focus on future business based on DexTech’s unique […]
Half-year report July 1, 2021 – December 31, 2021
15 February, 2022By “Company” or “DexTech” is meant DexTech Medical AB with organization number 556664-6203. Summary of the Second Quarter (2021-10-01 – 2021-12-31) Net sales amounted to MSEK 0,0 (0,0) Operating profit/loss […]
Last day of trading in BTA
24 January, 2022DexTech Medical AB (“DexTech” or the “Company”) hereby announces that the last day of trading in Paid Subscribed Shares (Sw. BTA) will be on 27 January 2022 and stop day […]
DexTech Medical AB announces outcome of finalized rights issue
27 December, 2021The subscription period of the rights issue of shares in DexTech Medical AB (“DexTech” or the “Company”), where also the public was able to subscribe for shares, ended on the […]
Today, the subscription period for DexTech Medical AB’s rights issue begins
8 December, 2021Today, the subscription period begins in DexTech Medical AB’s (“DexTech” or “the Company”) new issue of shares with preferential rights for existing shareholders (the “Rights Issue”). The public is also […]